A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
PHASE1
This substudy is part of an umbrella platform study which is designed to ev...
Status
Recruiting
Location
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 1045)
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
PHASE1
Researchers are looking for new ways to treat people with urothelial cancer...